Purpose Paper-based nutrition screening tools can be challenging to implement in the ambulatory oncology setting. The aim of this study was to determine the validity of the Malnutrition Screening Tool (MST) and a novel, automated nutrition screening system compared to a 'gold standard' full nutrition assessment using the Patient-Generated Subjective Global Assessment (PG-SGA). Methods An observational, cross-sectional study was conducted in an outpatient oncology day treatment unit (ODTU) within an Australian tertiary health service. Eligibility criteria were as follows: ≥18 years, receiving outpatient anticancer treatment and English literate. Patients self-administered the MST. A dietitian assessed nutritional status using the PG-SGA, blinded to the MST score. Automated screening system data were extracted from an electronic oncology prescribing system. This system used weight loss over 3 to 6 weeks prior to the most recent weight record or age-categorised body mass index (BMI) to identify nutritional risk. Sensitivity and specificity against PG-SGA (malnutrition) were calculated using contingency tables and receiver operating curves. Results There were a total of 300 oncology outpatients (51.7 % male, 58.6±13.3 years). The area under the curve (AUC) for weight loss alone was 0.69 with a cut-off value of ≥1 % weight loss yielding 63 % sensitivity and 76.7 % specificity. MST (score ≥2) resulted in 70.6 % sensitivity and 69.5 % specificity, AUC 0.77. Conclusions Both the MST and the automated method fell short of the accepted professional standard for sensitivity (~≥80 %) derived from the PG-SGA. Further investigation into other automated nutrition screening options and the most appropriate parameters available electronically is warranted to support targeted service provision.
Introduction
It is widely acknowledged that malnutrition is underdiagnosed and under-treated in patients with cancer. Nutritional status influences morbidity, response to or tolerance of treatment, quality of life, hospital admission rates, and health care costs [1] [2] [3] . The prevalence of cancer-related malnutrition has been reported to be as high as 80 % [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] ; figures likely influenced by divergent definitions of malnutrition, tumour type and stage, as well as treatment regimen [14] .
Evidence-based guidelines for the management of malnutrition [15] in relation to patients with cancer [16, 17] recommend routine nutrition screening to identify 'at risk' patients using a tool validated in the oncology setting. Nutrition screening is used to quickly and easily identify high risk patients for subsequent referral to an appropriately trained clinician (usually a dietitian) for a comprehensive nutrition assessment and management plan [18] . Nutrition assessment involves a more detailed investigation considering medical and nutritional history, as well as objective anthropometric parameters to determine an individuals' nutritional status [13] .
In oncology, the Scored Patient-Generated Subjective Global Assessment (PG-SGA) is commonly used for nutrition assessment. The PG-SGA was developed for use with cancer patients and has been validated within ambulatory oncology settings [13, 12, 19] . However, given the cost (time and manpower) of nutritional assessment, it is not practical for all oncology outpatients to undergo nutritional assessment, hence the need for nutritional screening.
Traditional manual nutrition screening tools are currently favoured as a feasible method of rapidly identifying individuals at risk of malnutrition. However, despite being relatively less labour intensive than nutritional assessment, manual nutrition screening still requires staff time to undertake, to record results and to communicate referral to a dietitian. The Malnutrition Screening Tool (MST) has demonstrated good validity and reliability in identifying patients at risk of malnutrition in the oncology setting [8] and is commonly used to routinely screen for nutritional risk in patients with cancer in Australia. However, with growing patient numbers and limited staff resources, nutrition screening is often not prioritised in the outpatient setting, resulting in referrals being delayed or only made for those with visible physical signs of malnutrition [20] . In a recent audit of the Oncology Day Treatment Unit (ODTU) within this facility, 26 % of patients undergoing outpatient anticancer treatment were malnourished; alarmingly, 22 % had received no prior dietetic contact [21] . With the prospect of additional staffing to perform nutrition screening in this setting unlikely, despite a clear need for it, embedding screening within existing technology platforms was a viable alternative to explore. To our knowledge, there have been no studies in the oncology setting that have investigated an automated nutrition screening system. This study aimed to develop a novel, automated nutrition screening system and validate it against a full nutrition assessment using the PG-SGA tool. A secondary aim was to compare the sensitivity and specificity of the automated screening system with that of the patient-administered MST.
Materials and methods

Study design
This was a single site, cross-sectional, observational study. All participants provided informed consent before participation. The protocol received approval by the Metro South Human Research Ethics Committee.
Subjects
A convenience sample of eligible, consecutive patients was offered study entry. Eligibility criteria included aged 18 years or greater, receiving outpatient anticancer treatment, English literate and able to provide written consent.
Data collection
Data were collected over a 6-week period, Monday-Friday, during April-May 2013. Patient descriptive information on age, gender, cancer diagnosis, chemotherapy treatment protocol, chemotherapy cycle and day, previous treatments, concurrent treatment and year of diagnosis were collected from the participant's medical records. Data pertaining to prior cancer-related dietetic contact (i.e. location, date, current status in the dietetic system) were obtained from medical records and clarified with the patient or the treating dietitian. Cancer diagnoses were collapsed into six categories: breast, gastrointestinal, haematological, head and neck, lung and other.
MST
The MST is a nutrition screening tool [22] , found to have acceptable inter-rater reliability (kappa=0.03; P <0.001) when administered by dietitians, medical staff, nurses, administration staff and by patients themselves [8] . It comprises two questions relating to recent unintentional weight loss and poor eating as a consequence of decreased appetite. The tool provides a score between zero to five, with patients classed as 'at risk' of malnutrition if the score is equal to or greater than two [22] . Patients in this study self-administered a written MST and placed it into an envelope for collection by researchers. The data collectors were blinded to the patients' MST prior to undertaking their separate PG-SGA assessment.
PG-SGA
The PG-SGA consists of a medical and dietary history (weight loss, dietary intake, nutrition impact symptoms, functional capacity, metabolic stresses) and a physical assessment (subcutaneous fat, muscle atrophy and oedema). Height, weight and weight history data were obtained from patients' medical records, where possible. As in clinical practice, if these were unavailable, self-reported data were used. The PG-SGA produces the following global ratings: well nourished (SGA A), moderately malnourished (SGA B) or severely malnourished (SGA C) [20, 23] . The tool gives a total score (0-50), typically ranging from zero to thirty-five [24] . In the oncology setting, patients will score a minimum of one, with one point allocated on the basis of proven malignancy. Scores greater than nine indicate a critical need for nutrition-related symptom management [20] . The PG-SGA was undertaken on each participant once during a scheduled chemotherapy treatment. PG-SGA assessments were undertaken by two dietitians. Inter-rater reliability was assessed by duplicate ratings of several patients prior to commencement of data collection. The lead investigator reviewed all PG-SGA assessments and if agreement in the global rating and score was not reached, a senior researcher, blinded to both the MST and automated screening results independently reviewed the data to determine the PG-SGA rating.
Automated screening system
All chemotherapy regimens within this facility are prescribed, manufactured, supplied, and administered by way of the electronic prescribing system/medical record Charm TM software (charmhealth, Pty Ltd, V4.2.4). This electronic system supports the multidisciplinary team by providing patient-centric cancer treatment information at the point of care. A report was generated from the electronic system data that included name, age, patient identification number, measured weight (recorded from electronic scales, to the nearest 0.1 kg), measured height (recorded from a single wall-mounted stadiometer, to the nearest 0.01 m) and body mass index (BMI). The data from the electronic system that were used for comparison with PG-SGA consisted of weight loss data and BMI. BMI was calculated and categorised based on age: i.e. <65 years underweight (<18. [26] . Weight was measured at periodic medical review appointments prior to chemotherapy administration. Weight loss was calculated over a 3-to 6-week period prior to the most recent weight record in the electronic system. In the case of multiple weight records within this timeframe, the record closest to 30 days was used. BMI was used only if a weight change record was unavailable, e.g. only for patients new to chemotherapy or if weight was recorded outside the identified time period.
Data analysis
Data were entered into STATA version 13.0 [27] . Receiver operating characteristic (ROC) curves and contingency tables were generated to determine the sensitivity (percentage of malnourished correctly identified as such in comparison to the PG-SGA) and specificity (percentage of well nourished correctly identified as such compared to the PG-SGA). Positive predictive values (PPV) and negative predictive values (NPV) (i.e. the likelihood that the tool accurately predicts the presence or absence, respectively, of malnutrition) of the automated screening system compared to the PG-SGA were also calculated. This was similarly done for the MST. For the purpose of statistical analyses, nutritional status was classified as two groups: 'well nourished' (SGA A) and 'malnourished' with SGA B and SGA C merging.
Results
General characteristics of study participants Table 1 outlines the general characteristics of study participants. Three hundred twelve eligible patients were identified with 300 consenting (96.2 % participation). Reasons for nonparticipation included chemotherapy-associated fatigue and minimal remaining time of the chemotherapy infusion. The mean participant age was 58.6±13.4 years and 51.7 % were male (n=155). The most common cancer diagnoses were haematological (31.3 %), followed by gastrointestinal (21 %) and breast cancers (19.7 %).
Nutritional status and BMI
Using the PG-SGA global rating, 83 % (n=249) of participants were well nourished (PG-SGA A) and 17 % (n=51) were malnourished (SGA B, n=46; SGA C, n=5) ( Table 1) . Malnourished patients had significantly lower body weight and BMI than well-nourished patients (P=<0.001). Malnutrition varied between diagnoses (P=0.039), with 37.5 % of head and neck patients being malnourished, followed by 27 % of those with gastrointestinal malignancies, 14.9 % with haematological diagnoses, 12 % with lung and 10.2 % with breast malignancies. More than half of the participants (53 %, n=159) were overweight or obese for their age, whilst 7 % (n=21) were underweight.
Performance of the automated nutrition screening system and MST compared to PG-SGA Table 2 outlines the results. According to the MST, 37.2 % (n=112) of patients were at risk of malnutrition (score ≥2). The MST had a 70.6 % sensitivity and 69.7 % specificity compared to the PG-SGA. For the automated system, weight change data were available for 245 patients, age-categorised BMI was available for 40 patients without weight change data and 15 patients had no weight and height data recorded. Different cut-offs were used for these variables within the automated tool to determine the best sensitivity, specificity, predictive values and accuracy compared to the PG-SGA. Using cut-offs of weight loss of ≥1 % in 3 to 6 weeks or age-categorised underweight BMI, these variables provided 30.6 % sensitivity and 71.6 % specificity compared to the PG-SGA. When BMI was removed (n=245), the sensitivity of weight loss of ≥1 % was 63.0 % and specificity was 76.7 %.
Discussion
The best performing automated screening criteria using a combination of weight loss and underweight BMI (≥1 % weight loss in 3 to 6 weeks or age-categorised underweight BMI) showed reasonable specificity but low sensitivity against the full nutritional assessment by the PG-SGA. Once underweight, age-categorised BMI was removed, the sensitivity and specificity using the ≥1 % cut-off value improved, however still failed to reach the accepted professional standard of 80 %. We therefore cannot recommend any of the automated screening system methods in their current format. Further research into the most appropriate electronic parameters is warranted. It is worth exploring a wider time period for weight changes, as the one utilised in this study may have been too short. Furthermore, given that underweight age-categorised BMI alone performed poorly in sensitivity, this particular automated system may only have potential in monitoring patients who are at risk of malnutrition once they are well established on treatment.
The literature supports nutritional screening within the oncology population. However, studies to date have focused on manual, paper-based screening methods. This is the first study to investigate the effectiveness of an automated nutrition screening system to assess nutritional risk in the ambulatory oncology outpatient population. Research however has progressed in other clinical areas. In the surgical setting, Smith et al. [28] used Brugler's simplified screening tool for Cancer diagnosis: 'Gastrointestinal' cancer included colorectal (n=35), oesophageal (n=10), pancreatic (n=8), gastric (n=3), gall bladder (n=2), cholangiocarcinoma (n=2), duodenal (n=2) and appendiceal (n=1) cancers. 'Haematological' diagnoses included lymphoma (n=52), multiple myeloma (n=23), leukaemia (n=18) and myelodysplastic syndrome (n=1). 'Other' cancers included sarcoma (n=6), prostate cancer (n=4), carcinoma of unknown primary (n=2), renal cell carcinoma (n=2), germ cell tumour (n=2), medullablastoma (n=1) and seminoma (n=1) b Comparing well nourished to malnourished patients using chi-square test c Comparing well nourished to malnourished patients using independent sample t test malnutrition-related complications (MRCS) to rank six variables (three biochemical parameters, wound presence, presence of high risk illness, and poor nutritional intake) to enable automated screening in hospitalised patients. The MRCS proved to be the more predictive of postoperative complications compared to the SGA. The MRCS however has not been investigated outside the acute surgical setting and might not be transferable to the ambulatory oncology setting. Although the MST performed better than the automated system in this study, it also fell short of the accepted professional standard for sensitivity (~80 %) against the PG-SGA. Other studies of oncology populations have reported more acceptable sensitivity and specificity when comparing the MST to the PG-SGA. For example, Isenring et al. [8] reported 100 % sensitivity and 92 % specificity in 50 oncology outpatients with mixed diagnoses, while Ferguson et al. [29] reported 100 % sensitivity and 81 % specificity in 106 oncology outpatients undergoing radiotherapy. Gabrielson et al. [4] reported 81.3 % sensitivity and 72.4 % specificity in 90 chemotherapy outpatients with mixed diagnoses. The lower sensitivity in our study could be related to the MST being selfcompleted. Despite this tool being relatively quick and easy, its administration by clinicians in this particular outpatient setting has not been possible due to limited human and financial resources.
According to the PG-SGA global rating, the prevalence of malnutrition in this study was 17 %. Other studies of smaller samples using the SGA or PG-SGA identified malnutrition prevalence in oncology outpatients receiving chemotherapy around 25 % [8, 21] . A larger variation in malnutrition prevalence was found using the SGA or PG-SGA in oncology outpatients undergoing radiotherapy, with findings between 11-35 % [24, 29] . Despite the reduction in malnutrition at this site compared to a previous audit [21] , 41.2 % of malnourished patients in the present study (n=21) were not known to the dietetic system, confirming the need for formalised nutrition screening in this setting.
The strengths of this study are that nutritional assessments were conducted by dietitians blinded to nutritional screening results, the relatively large sample size, the representative sample of patients recruited and the excellent participant response rate. Limitations include no weight and height data being available for 5 % (n=15) of patients undergoing anticancer treatment in the study.
Conclusion
With the direction of medical records trending towards electronic systems, the investigation of automated or computerised nutrition screening systems is timely. Nonetheless, challenges do exist. Electronic medical record systems can provide benefits in terms of efficiency, safety and timely access to information; however, there are notable risks if they are not properly implemented, maintained or used. Whilst the present study did not demonstrate acute weight change within a 3-to 6-week period to be a valid screening method, it will inform future research into novel automated screening tools to manage the vast numbers of cancer patients receiving chemotherapy to support targeted dietetic service provision. Suggestions for future studies are to explore the most clinically relevant electronic nutritional parameters.
